Seeking Alpha

Kevin Porter

Kevin Porter
Send Message
View as an RSS Feed
View Kevin Porter's Comments BY TICKER:
Latest  |  Highest rated
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    that's basically false again

    The efficacy vote was 4-5 against BUT
    each panelist was asked to give their color on their vote and three of the five who voted no said that they would've voted yes for the efficacy, they believe it was efficacious, they just couldn't bring themselves as clinical trialists to vote yes when a primary endpoint hasn’t been met.

    so it's more like 7-2 on efficacy and 4-5 on super efficacy (super-superiority)

    the device does work

    after so many lies I am not interested in discussing with you anymore.
    end of discussion.
    Aug 22 02:03 PM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    Efficacy: False
    Unless you have been drunk for the last 3 months, ADCOM voted 6-2 on benefits vs risks, or were all the experts drunk ?

    Price: False
    ''Our device will most likely be priced in between a gastric band and gastric bypass, which cumulatively (device, surgeon fees, OR time, etc) cost 15-20K and 30+K respectively.''

    Selling Abroad: False
    They haven't pursued selling abroad yet

    Insurance: False
    They will very likely get type I coverage after FDA approval

    No reason to have surgery vs pills: False
    200K bariatric surgeries are performed annually in the USA and that is only a fraction of the potential patient population, which is in the multimillions.
    Even just a potential 10K surgeries a year would skyrocket ETRM 4x-6x the current price.

    Safety profile: False
    Unless you have been drunk for the last 3 months, ADCOM voted 8-1 on the safety profile, or were all the experts drunk ?
    Aug 22 10:07 AM | 1 Like Like |Link to Comment
  • Arena To Present At Jefferies Conference - Is It A Catalyst? [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap:
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price.
    Aug 22 09:25 AM | 1 Like Like |Link to Comment
  • Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap:
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:24 AM | 1 Like Like |Link to Comment
  • Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all.

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:21 AM | 1 Like Like |Link to Comment
  • Arena Pharmaceuticals: Strong Sell On Multiple Red Flags [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:20 AM | 1 Like Like |Link to Comment
  • Arena Stock Rises With Expected Jump In Belviq Sales [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price.
    Aug 22 09:16 AM | 1 Like Like |Link to Comment
  • Arena Sees Belviq Sales Climb Despite Seasonality [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:15 AM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    marmer, really ridiculous

    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:12 AM | 1 Like Like |Link to Comment
  • VRNG OUT 5.02 [View instapost]
    Yes, I should have sold 100%, but anyway 75% is good enough. Even if the last 25% went to zero the overall trade would be still pretty good. Maybe it could be interesting to buyback some in the 0.60s or 0.50s.
    Aug 15 05:37 PM | 1 Like Like |Link to Comment
  • ETRM Valuation [View instapost]
    I wouldn't be surprised by a sudden $5-7 offer
    Aug 13 03:01 PM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    yes, the NIH launching a 248M body’s electrical wiring programme is good
    Aug 11 10:30 AM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    ETRM is worth $7-10 on its patents alone:

    Energy Efficient Neuromodulation
    Systems for regulation of blood pressure and heart rate
    NERVE STIMULATION AND BLOCKING FOR TREATMENT OF GASTROINTESTINAL DISORDERS
    Pancreatic exocrine secretion diversion apparatus and method
    REMOTE MONITORING AND CONTROL OF IMPLANTABLE DEVICES
    Controlled vagal blockage therapy
    Nerve stimulation and blocking for treatment of gastrointestinal disorders
    DEVICES FOR REGULATION OF BLOOD PRESSURE AND HEART RATE
    SAFETY FEATURES FOR USE IN MEDICAL DEVICES
    Implantable therapy system having multiple operating modes
    Remote monitoring and control of implantable devices
    Bulimia Treatment
    Methods and systems for glucose regulation
    Antenna arrangements for implantable therapy device
    Obesity treatment and device
    Implantable device with heat storage
    Implantable therapy system with external component having multiple operating modes
    Neural electrode treatment
    NEURAL MODULATION DEVICES AND METHODS
    Irritable bowel syndrome treatment
    GI inflammatory disease treatment
    Gastro-esophageal reflux disease (GERD) treatment method and apparatus

    Patent Protection up to July 2034 and many more patents yet to be issued
    Aug 11 08:44 AM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    I post all my trades in realtime through my Instablogs. I am long at $1.35

    The market works on realtime trading, not blah blah blah.
    I advise everyone to trust only people posting their calls in realtime.

    Now end your ridiculous personal attacks and false info or you will be reported.
    Aug 10 11:04 AM | Likes Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    Prostate devices would be kind of easy. ETRM started with the vagus nerve then will work its way to the sciatic nerve then eventually the brain for stimulation with electric impulses.
    This field is just beginning. If I was GSK or MDT I would offer $8 a share right now for ETRM.
    The patents alone are worth that. ETRM has the full coverage.
    Aug 10 10:49 AM | 1 Like Like |Link to Comment
COMMENTS STATS
1,735 Comments
3,353 Likes